OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/02/2026
Back to search
Official data from USPTO
GIV·IN PV GIVINOSTAT IN POLYCYTHEMIA VERA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Quick snapshot
ST13
US500000079406926Class
35, 41, 42, 45
Filing
79406926
Registration
7741742
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
04/03/2026
Classification
Registered
Trademark type
Combined
Nice classes
35, 41, 42, 45
Filing date
02/21/2024
Registration date
04/01/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2025
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IT
Examiner
O'BRIEN, JENNIFER LYNN
Law office
N30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "GIV IN PV" in capital letters, the parts "GIV" and "IN" being in green color separated by a full circle also in green color, the "PV" part being black in color, such parts being placed above the wording "GIVINOSTAT IN POLYCYTHEMIA VERA" in smaller size in black color except for the letters "GIV IN PV" in green color and being placed to the left of the entire wording are three elongated red ovals connected in the middle.
Holders and representatives
Holders
ITALFARMACO S.P.A.
Representatives
Cynthia A. Moyer FREDRIKSON & BYRON, P.A.
Technical classification
Nice Classes
Class 35Class 41Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Management of business projectsnamely management of clinical trial projects in the nature of providing information management services; recruitment and selection of personnel and experts for clinical trials; business management of clinical trials; outsourcing services in the nature of arranging service contracts for others in the field of pharmaceutical development and clinical research; records management servicesnamely indexing of documents for third partiesespecially coordination and control of electronic and paper document flow; database management services in the field of pharmaceutical product developmentpreparation of case report forms (CRFs); collection and compilation of data into a central storage in the field of clinical trials; compilation and provision of statistical and biostatistical information in the nature of statistical analysis and reporting services for business purposes; medical coding services for third partiesnamely coding of clinical trial data for the purposes of medical science and of regulatory reviews and approvals in the nature of compilation and systemization of information into computer databases; compilation of data into computer databases for the purpose of medical science research and medical consultation; regulatory document submission managementnamely compiling dossiers in electronic common technical document formatsannual reportsmanagement of article submissions in the nature of records management servicesnamely document indexing for others.
Class 41
Education servicesnamely conducting seminarsconferencesworkshopstraining sessions in the field of clinical trial managementpharmaceutical developmentregulatory compliance; training services in the field of clinical trial coordinationbiostatisticsdata management; organization and execution of conventionseventscongressesseminarsconferencessymposiaexhibitions in the field of pharmaceutical and medical research; publication of textsother than publicity texts; on-line publication of books and specialized magazines; multimedia publication of magazinesspecialized magazines and newspapers; arranging and organization of meetings in the nature of seminarsworkshops and social entertainment eventsnamely networking events in the field of pharmaceutical drug development and clinical research; regulatory document submission managementnamely publishing presentations as printed matter.
Class 42
Scientific and technological services namely scientific researchanalysistestingdata computer modeling services in the field of pharmaceutical developmentclinical trialsmedical technology; scientific services and scientific researchnamely conducting scientific pharmaceutical product feasibility studies and product designing medical devices and instruments for clinical trials; scientific services and product designnamely conducting scientific pharmaceutical product feasibility studies and designing medical devices and instruments for clinical trials; platform as a service (PAAS) comprising software platforms for the transmission of imagesaudiovisual contentvideo content and messages; scientific research for medical purposes; product research servicesdesign and development of instruments for control and diagnostics; computer diagnostic servicescomputer system analysis services; scientific research; electronic data storage; technical writingnamely medical writing services for clinical protocolsstudy reportsregulatory dossiers; providing online non-downloadable software featuring clinical study and clinical trial management system tools via a website; electronic storage of files and documents; providing online non-downloadable software providing access to study management files; programming of software for study management files and electronic storage services for archiving temporary files throughout the clinical study lifecycle; scientific researchnamely programming of software for biostatisticsdevelopment of protocols for sample size and statistical power calculationsrandomization plansstatistical analysis plans; providing online non-downloadable software enabling interpretation and reporting of data for clinical trial reports and publications; product development for others; scientific researchnamely intermediate analysis for early decision-making in clinical trials; providing online non-downloadable software for providing access to databases and data lists ready for a New Drug Application (NDA)regulatory submission-compliant data filesstudy data tabulationdata on model regulatory submission standards; medical research and development for new products for others in the field of medical surveillance and safety plans; pharmaceutical drug development services; drug discovery services of adverse events from clinical trials; pharmaceutical drug development servicesnamely development of safety update reportsmanagement safety plansmedical surveillance plans; product quality testing of clinical trial's documentationfor examplestandard operating procedures (SOPs) and work instructionsinternal system reviewssite auditsprovider evaluations; medical research in the field of pharmacologynamely study design optimizationmodeling of pharmacokinetic population and pharmacodynamic interactions; Information related to scientific and medical research in the area of clinical trialsnamely the design of clinical trials and outcome measures for studying human diseasesstudying or testing drugsdevicesmedical treatment methods on humans; Custom computer programming in the field of image training and integration into computer systems of suitability data with interactive response technology (IRT); Product design and development of computer databases for the collectionstoragemanagementanalysisvalidation of data for use in the medical and pharmaceutical fields; Electronic data storage services for archiving presentations.
Class 45
Regulatory compliance consultancynamely legal assistance to third parties in drafting and compiling applications for new drugs; legal services relating to the submission and lifecycle management of clinical trial applications to competent authoritiesethics committeesregulatory agencies; legal assistance concerning the submission of amendments to applications for regulatory approval.
Publications
History of USPTO decisions and trademark events.
29 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/16/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/16/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
11/07/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/17/2025
FIMP
FINAL DISPOSITION PROCESSED
10/17/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/02/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
04/01/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2025
PUBO
PUBLISHED FOR OPPOSITION
02/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/21/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
01/17/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/17/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
01/17/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/17/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/03/2024
RFNT
REFUSAL PROCESSED BY IB
11/23/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/04/2024
RFRR
REFUSAL PROCESSED BY MPU
11/04/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/29/2024
CNRT
NON-FINAL ACTION WRITTEN
10/28/2024
DOCK
ASSIGNED TO EXAMINER
10/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
10/18/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/18/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/17/2024
Continuous trademark protection
Get notified about every new filing that threatens GIV·IN PV GIVINOSTAT IN POLYCYTHEMIA VERA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.